

“… BioNexus and our partners see real opportunity, real promise to impact Kansas City in a very positive way, both economically and for the health of everyone in the region.”Īlong with providing opportunity within Kansas City, Digital Health KC is set to make the region’s reputation more well-known to those across the globe, said Maria Flynn, founder and CEO of Ambiologix and advisory board chair of Digital Health KC. “What we’ve never had is a concerted, focused, coordinated effort focused on bringing everybody that’s working in and around this space together for the benefit of the region - until now,” Ridenour said. Digital Health KC positions Kansas City to be a global leader in the research, development and application of healthcare technology, said Dennis Ridenour, president and CEO of BioNexus KC.

The newly-launched initiative was founded by BioNexus KC, a local nonprofit highlighting the life science resources and their value to the community through collaboration and commercialization. Dennis Ridenour, BioNexus KC, speaks during a launch event for Digital Health KC
